Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELSM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,629
Award facts
- Contract value 100% obligated
- $17,628.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $17,628.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 30, 2026. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.99 billion ceiling value through December 31, 2036. The delivery order required completion by February 2, 2026, with no set-aside designation applied, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products to the Department of Defense healthcare system, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals, positioning it as a critical supplier within the federal military medical supply chain. The PPV-G GEN V program represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement across the Defense Logistics Agency's Medical Supply Chain division, enabling the issuance of delivery orders for recurring medical supply needs at military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FELSM?
SPE2DU26FELSM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DU26FELSM worth?
The government has obligated $17,629 on SPE2DU26FELSM.
Is contract SPE2DU26FELSM an order under another contract?
Yes. SPE2DU26FELSM is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELSM competed?
The extent of competition for SPE2DU26FELSM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award